Digital Twins and Systems Oncology: Revolutionizing Cancer Management

Abstract

Cancer remains one of the most biologically complex diseases, characterized by remarkable genomic diversity, dynamic tumor evolution, immune heterogeneity, and continuous interactions between malignant cells and the surrounding microenvironment. Despite significant advances in molecular diagnostics, targeted therapeutics, immunotherapy, and precision medicine, considerable variability in treatment response and clinical outcomes persists among patients with apparently similar tumor characteristics. Recent advances in artificial intelligence (AI), systems biology, computational oncology, mathematical modeling, and multimodal biomedical data integration have introduced digital twin technology as a transformative approach for personalized cancer management. A digital twin is a continuously evolving computational representation of an individual patient that integrates radiological imaging, digital pathology, genomic sequencing, transcriptomics, proteomics, metabolomics, laboratory biomarkers, physiological monitoring, electronic health records, and longitudinal clinical data to simulate disease progression and therapeutic response. Unlike conventional predictive models that analyze isolated datasets, digital twins continuously update through real-time patient information, enabling dynamic prediction of tumor evolution, treatment efficacy, toxicity, resistance mechanisms, and long-term clinical outcomes. Artificial intelligence technologies including machine learning, deep learning, transformer architectures, graph neural networks, reinforcement learning, multimodal learning, and foundation models have substantially accelerated digital twin development within oncology. These intelligent systems have demonstrated promising applications across cancer diagnosis, radiogenomics, computational pathology, immunotherapy, adaptive radiation therapy, surgical planning, drug discovery, clinical trial optimization, and precision therapeutics. Nevertheless, challenges remain regarding data standardization, interoperability, computational complexity, explainability, cybersecurity, ethical governance, regulatory validation, and widespread clinical implementation. This review explores the integration of digital twins and systems oncology, emphasizing computational foundations, clinical applications, emerging innovations, and future perspectives for revolutionizing personalized cancer management.[1]